CytomX Therapeutics (CTMX) Preferred Dividend Payments (2014 - 2015)
CytomX Therapeutics (CTMX) reported Preferred Dividend Payments of $558000.0 for Q4 2015, down 53.34% on a YoY basis from $1.2 million in Q4 2014, and down 81.14% quarter-over-quarter from $3.0 million in Q3 2015.
CytomX Therapeutics (CTMX) Preferred Dividend Payments (2014 - 2015) Analysis & Trends
CytomX Therapeutics has reported Preferred Dividend Payments for 2 years, with the latest figure at $558000.0 in Q4 2015.
- For the quarter ending Q4 2015, Preferred Dividend Payments fell 53.34% year-over-year to $558000.0; the trailing twelve-month figure through Dec 2015 stood at $6.7 million (changed N/A YoY), and the FY2015 full-year result was $6.7 million, up 46.85% from the prior year.
- Preferred Dividend Payments for Q4 2015 stood at $558000.0, down from $3.0 million in the prior quarter.
- The five-year high for Preferred Dividend Payments was $3.0 million in Q3 2015, with the low at $558000.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | CytomX Therapeutics | 520.30 Mn | 173.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 558,000.00 |
| Sep 30, 2015 | 2.96 Mn |
| Jun 30, 2015 | 1.76 Mn |
| Mar 31, 2015 | 1.43 Mn |
| Dec 31, 2014 | 1.20 Mn |
| Sep 30, 2014 | 1.17 Mn |